Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Validating Cell-Based Assays for use with 3D Culture Models

Summary

There is an unmet need for guidelines for design and verification of assays effective for larger 3D microtissues. Critical factors to consider include effective penetration of detection reagents and complete lysis of cells. We will present results from improving protocols for measuring cell viability and various cell health markers in 3D cultures. Join us for this InSphero hosted webinar in collaboration with Promega during their Summer School webinar series.


Speaker

terry-riss-125x126

Dr. Terry Riss
Global Strategic Marketing Manager, Cell Health
Promega Corporation

Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and held several R&D and Project Management positions since. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and also lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death.  Dr. Riss now serves as Global Strategic Marketing Manager, Cell Health involved in outreach educational training activities including validating assay systems applied to 3D cell culture models.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up